Nicholas Muraoka, DO
Pain Medicine · Honolulu, HINPI 1295034866
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Medtronic at 29.5% of the total.
Across 33 payments — averaging $52.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$513
- Abbott$271
- Boston Scientific$260
- MML US, Inc.$136
- Si-bone, Inc.$126
- Mallinckrodt Enterprises LLC$118
- plus $319 from 7 others
What the payments were for
- Food & beverage$1,742100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 13 | $513 |
| Abbott | 5 | $271 |
| Boston Scientific | 5 | $260 |
| MML US, Inc. | 1 | $136 |
| Si-bone, Inc. | 1 | $126 |
| Mallinckrodt Enterprises LLC | 1 | $118 |
| Vertex | 1 | $116 |
| Pacira Therapeutics, Inc. | 1 | $80 |
| Stryker | 1 | $44 |
| Tersera Therapeutics LLC | 1 | $24 |
| Merz North America, Inc. | 1 | $20 |
| AbbVie | 1 | $19 |
| Nevro Corp. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMED$175
- ReActiv8$136
- iFuse Implant$126
- RESTORE$125
- WaveWriter Alpha Prime 16$122
- OFIRMEV$118
- JOURNAVX$116
- ETERNA$109
How this compares
Too few pain medicine providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MovantikNaloxegol Oxalate | 17 | $11,382 |
| Gabapentin | 147 | $3,671 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 92 | $2,489 |
| Oxycodone Hcl | 132 | $2,354 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 87 | $2,165 |
| Pregabalin | 73 | $2,165 |
| Lidocaine | 16 | $2,039 |
| Fentanyl | 16 | $1,685 |
| Baclofen | 54 | $1,631 |
| Duloxetine Hcl | 31 | $1,129 |
| Morphine Sulfate ErMorphine Sulfate | 27 | $1,088 |
| Morphine Sulfate | 42 | $1,085 |
| Tramadol Hcl | 63 | $1,013 |
| Cyclobenzaprine Hcl | 32 | $963 |
| Celecoxib | 27 | $902 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Honolulu
- Jeffrey WangHonolulu$32K
- Troy TadaHonolulu$18K
- Eric SunHonolulu$6K
- Louis PauHonolulu$4K
- Daniel BurdickHonolulu$994
- Robert HymanHonolulu$564
- Roy EsakiHonolulu$91
- John SheehanHonolulu$79
- Daniel FischbergHonolulu$20
- Daniel ChoiKoloa$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.